Repligen Corporation
RGEN
$111.49
$1.371.24%
NASDAQ
| 12/31/2025 | 09/30/2025 | 06/30/2025 | 03/31/2025 | 12/31/2024 | |
|---|---|---|---|---|---|
| Revenue | 738.26M | 707.89M | 673.96M | 650.43M | 634.44M |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | 738.26M | 707.89M | 673.96M | 650.43M | 634.44M |
| Cost of Revenue | 349.54M | 342.70M | 330.31M | 317.73M | 315.77M |
| Gross Profit | 388.71M | 365.19M | 343.65M | 332.70M | 318.67M |
| SG&A Expenses | 287.24M | 250.80M | 251.08M | 246.98M | 238.28M |
| Depreciation & Amortization | -- | -- | -- | -- | -- |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | 690.16M | 645.43M | 628.85M | 608.50M | 596.79M |
| Operating Income | 48.10M | 62.46M | 45.10M | 41.93M | 37.65M |
| Income Before Tax | 62.38M | 4.66M | -13.60M | -22.79M | -27.04M |
| Income Tax Expenses | 13.49M | 2.92M | 228.00K | 193.00K | -1.52M |
| Earnings from Continuing Operations | 48.89 | 1.74 | -13.83 | -22.98 | -25.51 |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | 48.89M | 1.74M | -13.83M | -22.98M | -25.51M |
| EBIT | 48.10M | 62.46M | 45.10M | 41.93M | 37.65M |
| EBITDA | 126.84M | 139.62M | 119.66M | 113.39M | 107.30M |
| EPS Basic | 0.87 | 0.03 | -0.25 | -0.41 | -0.45 |
| Normalized Basic EPS | 0.61 | 0.74 | 0.61 | 0.57 | 0.51 |
| EPS Diluted | 0.85 | 0.01 | -0.26 | -0.42 | -0.46 |
| Normalized Diluted EPS | 0.61 | 0.74 | 0.61 | 0.57 | 0.51 |
| Average Basic Shares Outstanding | 224.93M | 224.68M | 224.43M | 224.08M | 223.74M |
| Average Diluted Shares Outstanding | 226.26M | 225.66M | 225.14M | 225.06M | 225.03M |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |